|Day Low/High||13.11 / 14.70|
|52 Wk Low/High||8.90 / 14.88|
Ginkgo Bioworks bears were gripping about Scorpion Capital alleged "front running" their DNA short analysis by purchasing puts. Well, put activity is now way down - Friday's expiration was quite active - and Cathie Wood of ARK has reported that it...
I have been adding to my short all week. And, I have added to short today (at $100.03).
There was a lot of reaction to the Ginkgo Bioworks Holdings short report on Twitter Wednesday not too long after it was published.
In two or three months, you won't hear a word on this again much like we've seen on so many other names.
A new short - Ginkgo Bioworks Holdings , see here. More to come.
The mixed action on Monday is not a negative -- and here's why SPACs are getting interesting again.
But aggressive action by retail traders is one reason that I'm not too worried about a substantial correction at this time.